RI
Insider selling
Robert I Blum sold $615K of Cytokinetics Inc (CYTK) stock
Robert I Blum, President & CEO of Cytokinetics Inc (CYTK), sold 7,500 shares of CYTK stock worth $615K, per an SEC Form 4 filed Jul 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 13, 2026, 1 day before it was made public.
CYTK has moved -17.9% since the trade date, from $82.24 to $67.56 (Sep 21, 2026 close).
- Traded
- Jul 13, 2026
- Disclosed
- Jul 14, 2026
- Filing delay
- 1 day
- Price since
- -17.9%
- Role
- President & CEO
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.